Share Email Print
cover

Proceedings Paper

Lesion-specific laser catheters for angioplasty
Author(s): Douglas Murphy-Chutorian
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Since no one laser catheter can treat all types of disease, a new family of 'lesion-specific' devices was evaluated with a holmium laser source. Fifty patients (avg. 69 yrs) with lifestyle-limiting peripheral vascular disease and 29 patients (avg. 58 yrs) with symptomatic coronary disease were studied. Average lesion length was 5.3 cm in legs and 1.5 cm in hearts. A 1.5, 2.0, or 2.8 mm, tapered-tip or non-tapered, multifiber catheter (Eclipse, Palo Alto, CA) was advanced over the wire while emitting 300-1200 mj/pulse at 5 Hz. Mean percent stenosis decreased from 89% to 45% after lasing with a mean of 411 pulses in legs and from 86% to 46% with a mean of 158 pulses in hearts. Complications were infrequent. Laser technical success was 80% and overall procedural success was 97%. Conclusion: 1) Specialized laser catheters delivering holmium laser energy are capable of reducing the severity of peripheral and coronary stenoses including balloon angioplasty failures and bypass graft failures; 2) Follow-up studies are in progress to assess long term efficacy.

Paper Details

Date Published: 1 July 1991
PDF: 5 pages
Proc. SPIE 1420, Optical Fibers in Medicine VI, (1 July 1991); doi: 10.1117/12.43892
Show Author Affiliations
Douglas Murphy-Chutorian, Stanford Univ. (United States)


Published in SPIE Proceedings Vol. 1420:
Optical Fibers in Medicine VI
Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top